Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study).
Hanna HirschingerEvelyn JaegerStefanie NittkaSvetlana HetjensChristine LorenzConstanze RemiSusanne SausseleWolf-K HofmannDeniz GencerTobias BochPublished in: BMC palliative care (2024)
German Clinical Trials Registry DRKS00026775, registered 07.07.2022, Eudra CT No.: 2021-004789-36.